Katalog
Hilfe
Bauen Sie hier Ihr Portfolio auf
Geben Sie die Menge neben den benötigten Aktien ein – Ihr Portfolio wird automatisch erstellt.
Schneller Screener: nach Kategorie und Empfehlung filtern, Fundamentaldaten, Kennzahlen und Unternehmensprofile überprüfen.
| Unternehmen | Kategorie | Preis | Δ% | Div% | Vol20 | EPS(TTM) | QoQ | EPS(SPR) | Stil | Horizont | Pot. | Risiko | Empfehlung | Portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10x Genomics (TXG) | Biotechnologie | 71.55 | 0.00% | 0.0% | 0.0% | -0.59 | 0.1% | 0.0% | Wachstum | Mittel | 0 | 0 | — |
|
| Abivax (ABVX) | Biotechnologie | 88.01 | 0.00% | 0.0% | 2.7% | -6.66 | -200.0% | -74.7% | Wachstum | Mittel | 20 | 85 | Verkaufen |
|
| Alnylam Pharmaceuticals (ALNY) | Biotechnologie | 224.03 | 0.00% | 0.0% | 2.4% | 6.10 | 10.6% | -25.8% | Wachstum | Mittel | 34 | 75 | Verkaufen |
|
| Apogee Therapeutics (APGE) | Biotechnologie | 135.07 | 0.00% | 0.0% | 0.0% | -4.34 | 0.0% | -6.5% | Wachstum | Lang | 30 | 70 | Verkaufen |
|
| Arcus Biosciences (RCUS) | Biotechnologie | 18.54 | 0.00% | 0.0% | 3.0% | -3.93 | 141.2% | 0.0% | Wachstum | Mittel | 39 | 76 | Verkaufen |
|
| Arrowhead Pharmaceuticals (ARWR) | Biotechnologie | 58.02 | 0.00% | 0.0% | 2.0% | -2.24 | 2.1% | -6.3% | Wachstum | Mittel | 32 | 71 | Verkaufen |
|
| Bio-Techne (TECH) | Biotechnologie | 72.55 | 0.00% | 0.6% | 0.1% | 1.17 | 3.1% | 0.2% | Wachstum | Mittel | 61 | 40 | Kaufen |
|
| BioCryst Pharmaceuticals (BCRX) | Biotechnologie | 7.65 | 0.00% | 0.0% | 2.3% | -1.44 | 39.5% | 0.0% | Wachstum | Mittel | 30 | 70 | Verkaufen |
|
| Biohaven (BHVN) | Biotechnologie | 13.88 | 0.00% | 0.0% | 3.0% | -4.64 | 0.0% | -19.6% | Wachstum | Mittel | 74 | 61 | Kaufen |
|
| BioMarin Pharmaceutical (BMRN) | Biotechnologie | 55.95 | 0.00% | 0.0% | 1.7% | 0.38 | 29.2% | 26.7% | Wachstum | Mittel | 56 | 68 | Kaufen |
|
| BioNTech (BNTX) | Biotechnologie | 88.11 | 0.00% | 0.0% | 2.3% | -6.73 | -12.0% | -54.3% | Wachstum | Mittel | 26 | 76 | Verkaufen |
|
| CAMP4 Therapeutics (CAMP) | Biotechnologie | 3.30 | 0.00% | 0.0% | 3.2% | -2.23 | 37.5% | -174.3% | Wachstum | Mittel | 25 | 81 | Verkaufen |
|
| Celcuity (CELC) | Biotechnologie | 65.25 | 0.00% | 0.0% | 3.8% | -4.29 | 0.0% | -24.1% | Wachstum | Mittel | 30 | 77 | Verkaufen |
|
| Centessa Pharmaceuticals (CNTA) | Pharma | 40.50 | 0.00% | 93.8% | 0.0% | -1.78 | 0.0% | -36.8% | Wachstum | Mittel | 30 | 72 | Verkaufen |
|
| Cidara Therapeutics (CDTX) | Biotechnologie | 221.38 | 0.00% | 0.0% | 0.0% | -11.78 | 0.0% | 0.0% | Wachstum | Mittel | 20 | 80 | Verkaufen |
|
| Corcept Therapeutics (CORT) | Biotechnologie | 85.86 | 0.00% | 0.0% | 2.6% | 0.52 | 55.3% | 1383.3% | Wachstum | Mittel | 40 | 75 | Verkaufen |
|
| Corvus Pharmaceuticals (CRVS) | Biotechnologie | 10.53 | 0.00% | 0.0% | 3.3% | -0.64 | 0.0% | -19.4% | Wachstum | Mittel | 31 | 72 | Verkaufen |
|
| CPRX (CPRX) | Gesundheitswesen | 31.49 | 0.00% | 0.0% | 0.0% | 1.80 | -2.1% | 15.6% | Wachstum | Mittel | 52 | 52 | Halten |
|
| Crinetics Pharmaceuticals (CRNX) | Biotechnologie | 84.95 | 0.00% | 0.0% | 0.0% | -5.05 | 134.0% | 0.0% | Wachstum | Mittel | 70 | 80 | Halten |
|
| Definium Therapeutics (DFTX) | Biotechnologie | 35.67 | 0.00% | 0.0% | 3.2% | -3.44 | 0.0% | -166.2% | Wachstum | Mittel | 39 | 73 | Verkaufen |
|
| Dianthus Therapeutics (DNTH) | Biotechnologie | 76.78 | 0.00% | 0.0% | 2.3% | -0.13 | 64.4% | 0.0% | Wachstum | Lang | 39 | 71 | Verkaufen |
|
| Disc Medicine (IRON) | Biotechnologie | 74.51 | 0.00% | 0.0% | 8.8% | -6.60 | 0.0% | 9.9% | Wachstum | Mittel | 71 | 64 | Kaufen |
|
| EyePoint Pharmaceuticals (EYPT) | Gesundheitswesen | 0.40 | 0.00% | 0.0% | 18.8% | -3.74 | -27.2% | -7.9% | Wert | Mittel | 0 | 100 | Verkaufen |
|
| Forte Biosciences (FBRX) | Biotechnologie | 76.99 | 0.00% | 0.0% | 0.0% | -4.59 | 0.0% | 10.2% | Wachstum | Mittel | 70 | 69 | Halten |
|
| ImmunityBio (IBIO) | Biotechnologie | 0.72 | 0.00% | 0.0% | 4.9% | -0.33 | -100.0% | 42.3% | Wachstum | Mittel | 10 | 85 | Verkaufen |
|
| Immunovant (IMVT) | Biotechnologie | 28.41 | 0.00% | 0.0% | 2.3% | -2.82 | 0.0% | -19.3% | Wachstum | Mittel | 31 | 71 | Verkaufen |
|
| Incyte (INCY) | Pharma | 115.71 | 0.00% | 0.0% | 1.7% | 8.13 | 31.5% | 43.7% | Wachstum | Mittel | 67 | 41 | Kaufen |
|
| Intellia Therapeutics (NTLA) | Biotechnologie | 11.21 | 0.00% | 0.0% | 3.4% | -3.36 | -49.1% | -0.1% | Wachstum | Mittel | 30 | 80 | Verkaufen |
|
| Ionis Pharmaceuticals (IONS) | Biotechnologie | 42.93 | 0.00% | 0.0% | 2.2% | -3.46 | 8.9% | 0.0% | Wachstum | Lang | 24 | 85 | Verkaufen |
|
| Jazz Pharmaceuticals (JAZZ) | Biotechnologie | 214.00 | 0.00% | 0.0% | 1.6% | 15.20 | 13.0% | -7.6% | Ausgewogen | Mittel | 39 | 72 | Verkaufen |
|